Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag)

NCT06932198 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension (PAH)

Interventions

DRUG: Selexipag Film Coated Tablets
DRUG: Uptravi® Film Coated Tablets

Sponsor

Humanis Saglık Anonim Sirketi